Breathe BioMedical Inc. (BRTH)
Breathe BioMedical was planning to go public, but the IPO was withdrawn on Oct 28, 2024.
IPO Price Range
$4.00 - $6.00
Shares Offered
2,625,000
Deal Size
$13.13M
Breathe BioMedical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
26
Market Cap
57.36M undefined
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBRTH News
- 7 months ago - Canadian diagnostics developer Breathe BioMedical files for a $12 million dual listing in the US and Canada - Renaissance Capital
- 7 months ago - Breathe BioMedical IPO Registration Document (F-1) - SEC